Market Overview

Benzinga's Top Upgrades

Share:
Related AMGN
The Other Bearish Biotech ETF Is Looking Groovy, Too
These 6 Stocks Skyrocketed During The 2008 Crash
Approval Of Repatha May Give Amgen A $5B Boost. (Seeking Alpha)
Related PCS
Morgan Stanley Says Sprint's Headline EBITDA Should Be Strong
Google's New Wireless Service Aimed At 'Kids'

Piper Jaffray upgraded Amgen (NASDAQ: AMGN) from “neutral” to “overweight.” Amgen's shares closed at $79.29 yesterday. Amgen's trailing-twelve-month operating margin is 33.61%.

Deutsche Bank upgraded MetroPCS Communications (NYSE: PCS) from “hold” to “buy.” MetroPCS' stock closed at $8.59 yesterday. MetroPCS' trailing-twelve-month revenue is $4.93 billion.

Analysts at UBS upgraded Sprint Nextel (NYSE: S) from “neutral” to “buy.” Sprint's shares closed at $4.05 yesterday. Sprint had $7.57 billion in total cash for the latest quarter.

RW Baird upgraded AmerisourceBergen (NYSE: ABC) from “neutral” to “outperform.” AmerisourceBergen's shares closed at $37.96 yesterday. AmerisourceBergen's PEG ratio is 1.05.

Latest Ratings for AMGN

DateFirmActionFromTo
Jul 2015BarclaysMaintainsEqual-weight
Jul 2015UBSDowngradesBuyNeutral
Apr 2015JefferiesMaintainsBuy

View More Analyst Ratings for AMGN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AMGN + ABC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters